FDA Adverse Event Injury Summary report: N

VENTAK PRIZM 2

MDR report key: 2163393 · Received July 15, 2011

Report

Report Number
2124215-2011-07898
Event Type
Injury
Date Received
July 15, 2011
Date of Event
April 21, 2011
Report Date
April 21, 2011
Manufacturer
GUIDANT CRM CLONMEL IRELAND
Product Code
LWS
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
LA
Reporter Occupation
MEDICAL EQUIPMENT COMPANY TECHNICIAN/REPRESENTATIVE

Narratives

Additional Manufacturer Narrative · 1

AS NO ADDITIONAL INFORMATION CONCERNING THIS REPORT IS EXPECTED AT THIS TIME, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD ADDITIONAL INFORMATION BE PROVIDED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THE PATIENT WITH THIS IMPLANTED DEVICE WAS HOSPITALIZED AFTER PRESENTING TO AN EMERGENCY ROOM AFTER RECEIVING NUMEROUS INAPPROPRIATE SHOCKS. THE ASSOCIATED RIGHT VENTRICULAR (RV) LEAD HAD A RECENT HISTORY OF LOW PACE IMPEDANCE MEASUREMENTS, AND A BOSTON SCIENTIFIC TECHNICAL SERVICES CONSULTANT (TS) DISCUSSED THE POSSIBILITY OF A LEAD INSULATION ISSUE. IT WAS REPORTED THAT A PACING THRESHOLD COULD NOT BE OBTAINED DURING FOLLOW-UP TESTING, AND THERE WAS EVIDENCE OF INTERMITTENT UNDERSENSING. DURING CLINICAL ISOMETRIC EXERCISES, THE LEAD ALSO EXHIBITED INTERMITTENT OVERSENSING. THE SHOCK IMPEDANCE MEASUREMENTS WERE NORMAL AND STABLE. THE DEVICE'S TACHYCARDIA THERAPIES WERE PROGRAMMED OFF AFTER THE PATIENT WAS ADMITTED FOR PENDING ADDITIONAL INVESTIGATION. THE LEAD SUBSEQUENTLY WAS CAPPED AND REPLACED, AND THIS DEVICE WAS ELECTIVELY REPLACED, WITH NO ADVERSE PATIENT EFFECTS REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 VENTAK PRIZM 2 IMPLANTABLE CARDIOVERTER DEFIBRILLATOR LWS GUIDANT CRM CLONMEL IRELAND 1860

Patients

Seq Age Sex Outcome Treatment
1 58 YR Hospitalization 1860| 0157